NCT00111306View on ClinicalTrials.gov

Study of Epratuzumab in Systemic Lupus Erythematosus

PHASE3TerminatedINTERVENTIONAL

Enrollment

510

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG

epratuzumab

Trial Locations (18)

Unknown

Birmingham

Tucson

Los Angeles

Upland

Denver

Washington D.C.

Baltimore

New York

The Bronx

Durham

Winston-Salem

Tulsa

Charleston

Brussels

Debrecen

Amsterdam

Santander

Birmingham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

UCB Pharma

INDUSTRY